Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06192602Not ApplicableActive Not Recruiting

Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis

Role: collaborator

NCT06487195Not ApplicableActive Not Recruiting

Effects of a Peer-facilitated, Recovery-focused Self-illness Management Program for First-episode Psychosis

Role: collaborator

NCT04166019Not ApplicableCompleted

Effect of a Peer-led Self-management Program for Recent-onset Psychosis

Role: collaborator

NCT07129369Not ApplicableNot Yet Recruiting

Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program

Role: collaborator

All 4 trials loaded